Wegovy injection (semaglutide) is a prescription medication approved for chronic weight management in adults and certain adolescents with obesity, or in adults who are overweight with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
8 Challenges and Considerations in Multi-Agonist Therapy Despite their advantages, GLP-1-based therapies face several challenges in adolescent populations: Gastrointestinal Side Effects: Nausea, vomiting, diarrhea, and constipation are common adverse events, especially during dose escalation
JAMA+ Trials highlights the implications and innovations of clinical trial research from across the JAMA Network to advance evidence-based medicine and public health
CREDENCE, Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation
Acceptance of the Research-Use-Only Acknowledgement is required at checkout
Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells